My Account
My Account My Orders My Settings Reorder Contact Us Sign Out
Who We Are
About Us2 Contact Us Petmeds4vets Rx App Privacy Policy Testimonials Mobile App Affiliate Program Vet/Shelter Program PetMeds® Cares Pharmacy Team 1800PetMeds Reviews
PetMeds® Investors Financial Press Releases Annual Reports & Proxy Statements Investor Presentation Corporate Governance Investor Contact SEC Filings Stock Quote Stock Chart
TV Commercials
National Association of Boards of Pharmacy Click to Verify - This site has chosen a GeoTrust SSL Certificate to improve Web site security PetMed Express Logo

1800PetMeds® Press Releases

Call Us: 1-800-738-6337
Email Us
01.28.2013


PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS QUARTERLY DIVIDEND



Pompano Beach, Florida, January 28, 2013 - PetMed Express, Inc. (NASDAQ: PETS) today announced that its Board of Directors declared a quarterly dividend of $0.15 per share on its common stock. The dividend will be payable on February 22, 2013, to shareholders of record at the close of business on February 8, 2013. The Company intends to continue to pay regular quarterly dividends; however the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.

Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2012. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.